[(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid

C34H37N5O3 — CID 135355528

IUPAC[(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid
SMILESCn1c(-c2cc3ccccc3n2Cc2ccccc2)nc2cc(C(=O)N3CCC[C@@H](N(C(=O)O)C(C)(C)C)C3)ccc21
InChIInChI=1S/C34H37N5O3/c1-34(2,3)39(33(41)42)26-14-10-18-37(22-26)32(40)25-16-17-29-27(19-25)35-31(36(29)4)30-20-24-13-8-9-15-28(24)38(30)21-23-11-6-5-7-12-23/h5-9,11-13,15-17,19-20,26H,10,14,18,21-22H2,1-4H3,(H,41,42)/t26-/m1/s1
InChIKeyJPYVWBVJWXZQDD-AREMUKBSSA-N
MW563.70 g/mol
LogP6.63
Rot. Bonds5

About [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid

[(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid (PubChem CID 135355528) has the molecular formula C34H37N5O3 and a molecular weight of 563.70 g/mol. Its IUPAC name is [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid.

Molecular Properties

Compound Name[(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid
PubChem CID135355528
Molecular FormulaC34H37N5O3
Molecular Weight563.70 g/mol
Exact Mass563.29
IUPAC Name[(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid
SMILESCn1c(-c2cc3ccccc3n2Cc2ccccc2)nc2cc(C(=O)N3CCC[C@@H](N(C(=O)O)C(C)(C)C)C3)ccc21
InChIInChI=1S/C34H37N5O3/c1-34(2,3)39(33(41)42)26-14-10-18-37(22-26)32(40)25-16-17-29-27(19-25)35-31(36(29)4)30-20-24-13-8-9-15-28(24)38(30)21-23-11-6-5-7-12-23/h5-9,11-13,15-17,19-20,26H,10,14,18,21-22H2,1-4H3,(H,41,42)/t26-/m1/s1
InChIKeyJPYVWBVJWXZQDD-AREMUKBSSA-N
XLogP6.63
TPSA83.60 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500563.70
LogP ≤ 56.63
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid?
The IUPAC name of [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid (CID 135355528) is [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid.
What is the SMILES notation for [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid?
The canonical SMILES for [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid is Cn1c(-c2cc3ccccc3n2Cc2ccccc2)nc2cc(C(=O)N3CCC[C@@H](N(C(=O)O)C(C)(C)C)C3)ccc21.
What is the InChIKey of [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid?
The InChIKey is JPYVWBVJWXZQDD-AREMUKBSSA-N. The full InChI is InChI=1S/C34H37N5O3/c1-34(2,3)39(33(41)42)26-14-10-18-37(22-26)32(40)25-16-17-29-27(19-25)35-31(36(29)4)30-20-24-13-8-9-15-28(24)38(30)21-23-11-6-5-7-12-23/h5-9,11-13,15-17,19-20,26H,10,14,18,21-22H2,1-4H3,(H,41,42)/t26-/m1/s1.
What are the key properties of [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid?
[(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid has a molecular weight of 563.70 g/mol, XLogP of 6.63, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(3R)-1-[2-(1-benzylindol-2-yl)-1-methylbenzimidazole-5-carbonyl]piperidin-3-yl]-tert-butylcarbamic acid is sourced from PubChem (CID 135355528), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).